New Science Ventures is a Greenwich, Connecticut and London–based venture capital firm founded in 2004 that invests in early and growth-stage companies applying fundamental scientific and technology innovation to address large unmet needs in life sciences and information technology sectors. The firm seeks differentiated opportunities with strong intellectual property and substantial market potential, partnering with founders from early development through key value inflection points. New Science Ventures manages significant committed capital and has a global investment footprint spanning the U.S., Europe, India, and China with a diversified portfolio across biotech, IT, advanced materials, and related deep tech areas. Its investment strategy emphasizes patient, science-driven approaches to building scalable enterprises. The firm’s leadership comprises experienced partners with expertise in venture, science, and technology industries.